scispace - formally typeset
W

Wolfgang Wagner

Researcher at Vienna University of Technology

Publications -  2508
Citations -  138154

Wolfgang Wagner is an academic researcher from Vienna University of Technology. The author has contributed to research in topics: Large Hadron Collider & Top quark. The author has an hindex of 156, co-authored 2342 publications receiving 123391 citations. Previous affiliations of Wolfgang Wagner include University of Pennsylvania & University of Amsterdam.

Papers
More filters
Journal ArticleDOI

Measurements of differential cross sections of top quark pair production in association with jets in pp collisions at √s=13 TeV using the ATLAS detector

Morad Aaboud, +2956 more
- 25 Oct 2018 - 
TL;DR: In this paper, the authors presented measurements of differential cross sections of top quark pair production in association with jets by the ATLAS experiment at the LHC and performed as functions of the top-quark transverse momentum.
Journal ArticleDOI

Measurement of the Lambda(0)(b) lifetime and mass in the ATLAS experiment

Georges Aad, +2889 more
- 04 Feb 2013 - 
TL;DR: In this paper, a measurement of the Lambda(0)(b) lifetime and mass in the decay channel is presented, which uses a signal sample of about 2200 Lambd...

The structure of public perceptions

Cjh Cees Midden, +7 more
Journal ArticleDOI

TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level

Khalid Abnaof, +12 more
- 15 May 2014 - 
TL;DR: The analysis of dynamical transcriptional response to TGF-β treatment experiments in different human and murine cell systems revealed commonly affected biological processes and pathways, which could be linked to T GF-β1 via network analysis.
Journal ArticleDOI

Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.

Karin Dieckmann, +5 more
- 01 Jul 2003 - 
TL;DR: In the risk-adapted treatment strategy of the HD-90 study, tumor burden indicated as bulky disease or as number of involved lymph nodes loses its importance, whereas NS2 histology and B-symptoms have a major impact on treatment outcome.